Shares of Bio-Techne Corp. TECH shed 2.04% to $58.73 Friday, on what proved to be an all-around poor trading session for the ...

Let’s dig into the relative performance of Bio-Techne (NASDAQ:TECH) and its peers as we unravel the now-completed Q4 research ...

Corporation announced further advancements in its ongoing strategy to bring translational discoveries to patient care by ...

Learn more about whether Repligen Corporation or Bio-Techne Corporation is a better investment based on AAII's A+ Investor ...

Bio-Techne Corporation ( NASDAQ:TECH ) shareholders might be concerned after seeing the share price drop 17% in ...

Dr. Gregory Bean, Associate Professor of Pathology at Stanford University, will describe the direct detection of mRNA from CRTC1/3::MAML2 translocations, as alternatives to MAML2 FISH, in the ...

Buy” on shares of Bio-Techne as a short-term investment idea. The firm expects Bio-Techne to report fiscal Q3 results in line or above ...

Equities research analysts at Evercore ISI assumed coverage on shares of Bio-Techne (NASDAQ:TECH – Get Free Report) in a ...

This was the stock's second consecutive day of losses.

MINNEAPOLIS, March 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care ...